Blog Post

GLOBAL ANDROLOGY FORUM

Publications

The Sixth Edition of the WHO Manual for Human Semen Analysis: A Critical Review and SWOT Analysis

Dec 02, 2023

The Sixth Edition of the WHO Manual for Human Semen Analysis: A Critical Review and SWOT Analysis.
Authors: Boitrelle F, Shah R, Saleh R, Henkel R, Kandil H, Chung E, Vogiatzi P, Zini A, Arafa M, Agarwal A.
Life (Basel). 2021 Dec 9;11(12):1368.

DOI: 10.3390/life11121368.

Preamble: Understanding Sperm Epigenetics
Epigenetics in male infertility involves changes that impact gene activity without altering the DNA sequence. For instance, DNA methylation modifications can affect sperm quality. Histone alterations during spermatogenesis impact the packaging of genetic material in sperm. Dysregulation of non-coding RNAs, like miRNAs, can lead to sperm function issues. These epigenetic changes can influence male fertility, affecting sperm function and potentially impacting fertility outcomes.

CAPSULE


Contributors: Christopher Ho, MD (Malaysia), Widi Atmoko, MD (Indonesia)

Semen analysis is a mainstay for initial evaluation among infertile men. Proper preparation, assessment, and interpretation are mandatory to avoid misdiagnosis or unnecessary treatment. After around 10 years since the last edition, the WHO released its newest sixth edition manual of semen examination and processing. The present article reviews the Sixth Edition of the WHO Manual for Human Semen Analysis,
including a thorough analysis of strengths, weaknesses, opportunities, and threats (SWOT)


What the 5th edition lacked; this 6th edition attempted to improve on. It includes adding new data from fertile men in Southern Europe, Asia, and Africa to increase the representativeness of all geographical areas. Nevertheless, there is still no representation from Saharan Africa or South America. This 6th edition also
acknowledges that the 5th percentile values of basic semen parameters alone are insufficient for accurate diagnosis of male infertility. However, this created a lack of reference threshold or decision internals to replace the 5th percentiles.


The manual introduces an updated laboratory technical guide on semen analysis, including comprehensive step-by-step procedures. For instance, it adopts the earlier classification of sperm motility, adds semen odor examination, and a detailed assessment of lower sperm concentrations. Some recommendations on quality control and quality assurance that can help guide optimum laboratory performance are provided in the manual.


In addition, sperm DNA fragmentation (SDF) and fluorescence in situ hybridization (FISH) are also introduced as extended tests of semen. SDF is considered the most discussed and promising addition in male infertility workup. Despite the introduction of SDF as an extended examination, there is still a lack of indication, criteria for interpretation and cut-off threshold values. Despite sufficient data saying otherwise, the 6th edition still considers oxidative stress (OS) tests as specialized and mainly research based procedures in the advanced test section.


The problem that can arise is that there are too many technical details and a lack of reference values in this 6th edition, which may put off clinicians from reading it. The lack of reference values may drive clinicians to use the 5th edition instead. More importantly, clinicians should consider multiple factors, such as the patient's clinical status and female factors in fertility assessment to provide a thorough diagnosis.


The changes in the sixth edition of the WHO manual of human semen examination and processing have offered a great understanding of how to carry out a proper semen analysis. However, there is room for updates and improvement. This review by GAF authors rightfully said that future research may help overcome weakness in this 6th edition to help produce a better edition in the future, especially with the help of SWOT analysis.


Considering that clinicians must evaluate the strengths and drawbacks of the existing manual and reach a reasonable decision specific to each patient's situation, the review has completely analyzed and broken down the gist of the 6th edition so eloquently that it is an excellent supplement for busy clinicians who do not have the time to sieve through too many pages of jargon.

Christopher Ho Chee Kong, MD, MS, MRCSEd, MBU (Cert), MFSTEd, FAMM, FICS (USA), FRCS (Urol)(Glasg), FECSM, FRCSEd, FACS: Short Biography

Prof. Christopher Ho Chee Kong
Consultant Urologist,
Oriental Melaka Straits Medical Centre
Adjunct Professor, School of Medicine,
Taylor’s University
Kuala Lumpur, Malaysia

Prof. Dr. Christopher Ho Chee Kong is an Adjunct Professor in the School of Medicine, Taylor's University and Consultant Urologist at Oriental Melaka Straits Medical Centre. He was previously Professor of Surgery and Urology at Universiti Kebangsaan Malaysia (UKM).


Chris is a member of the International Consultation of Urological Diseases (ICUD), the Vice President for the Malaysian Society of Andrology and the Study of the Aging Male (MSASAM), Senior Vice President of the College of Surgeons Malaysia, Vice Chair of the International Society for Sexual Medicine Communications Committee, Committee Member of the Asian Society of Men’s Health and Andrology (AMSHA) and also a Fellow of the Royal College of Surgeons of Edinburgh (FRCSEd), and Glasgow FRCS (Urol)(Glasg), European Committee of Sexual Medicine (FECSM), International College of Surgeons (FICS), European Committee of Sexual Medicine (FECSM), American College of Surgeons (FACS) and Academy of Medicine Malaysia (FAMM).


He is also a Member of the Faculty of Surgical Trainers Edinburgh (MFSTEd), Société Internationale d'Urologie (SIU), Examiner for the Membership of the Royal College of Surgeon (MRCS) exam, tutor for the Edinburgh Surgical Sciences Qualification (ESSQ), Director of Andrology Special Interest Group for the Malaysian Urology Association.


He has published over 155 publications in peer reviewed journals as well as 7 book chapters on issues in Men’s Health. He is also a member of the Editorial Board of 10 journals (including the Investigative and Clinical Urology journal, SIU journal) and a reviewer for more than 24 journals.

Widi Atmoko, MD, FECSM, FICS: Short Biography

Widi Atmoko, MD
Andro-Urology Consultant
Cipto Mangunkusumo Hospital, Faculty
of Medicine Universitas Indonesia
Head of Urology Dept
Universitas Indonesia Hospital
Head of Uro-Nephrology Cluster,
Kencana Cipto Mangunkusumo Hospital
Jakarta, Indonesia

Dr. Widi Atmoko is a consultant urologist at the Department of Urology, Faculty of Medicine, Universitas Indonesia, Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia. He earned his medical degree and specialty with cumlaude distinction and is now pursuing a Doctoral degree from the same university. In 2020, he became a certified Andro-urologist consultant, and in 2023, he was recognized as a Fellow by the European Committee of Sexual Medicine.

Dr. Atmoko is the President of the Indonesian Society of Andrological Urology, Head of the Urology Department at Universitas Indonesia Hospital, and Head of Uronephrology Cluster at Kencana Dr. Cipto Mangunkusumo Hospital. Beyond these roles, he has been actively involved in other key positions, including the Head of Information, Technology, and Public Relations at InaUA, a member of SIU Academic Committee for the Sexual and Reproductive Section, and editorial board member of Video Journal of Sexual Medicine. Additionally, he serves as one of the research team leaders in the Global Andrology Forum.


Dr. Atmoko's contributions include over 60 scientific articles and chapters in reputable journals and books. His accomplishments are backed by several research grants and his selection for international fellowship and observership programs from esteemed organizations.


Dr. Widi serves as the Leader of Research team 7.

Acknowledgement: Chris and Widi contributed to this week’s Management Special. We are grateful for their outstanding support over the years.

Share by: